STX buy signal a huge momentum breaks channel with force. we 75% of probability we will see a bullish trend after pull back
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.04 GBP
−26.78 M GBP
10.53 M GBP
510.78 M
About SHIELD THERAPEUTICS PLC ORD GBP0.015
Sector
CEO
Karl Anders Lundström
Headquarters
Gateshead Quays
Website
Founded
2015
ISIN
GB00BYV81293
FIGI
BBG009YWHXG4
Shield Therapeutics Plc is a commercial stage specialty pharmaceutical company, which engages in addressing iron deficiency with its lead product Accrufer. It operates the Feraccru and PT20 segments. The Feraccru segment refers to the development and commercialization of this product. The PT20 segment related to the development of its secondary asset. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Gateshead Quays, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of STX is 2.65 GBX — it has decreased by −1.63% in the past 24 hours. Watch SHIELD THERAPEUTICS PLC ORD GBP0.015 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange SHIELD THERAPEUTICS PLC ORD GBP0.015 stocks are traded under the ticker STX.
STX stock has fallen by −2.53% compared to the previous week, the month change is a −6.71% fall, over the last year SHIELD THERAPEUTICS PLC ORD GBP0.015 has showed a −59.74% decrease.
We've gathered analysts' opinions on SHIELD THERAPEUTICS PLC ORD GBP0.015 future price: according to them, STX price has a max estimate of 29.95 GBX and a min estimate of 3.48 GBX. Watch STX chart and read a more detailed SHIELD THERAPEUTICS PLC ORD GBP0.015 stock forecast: see what analysts think of SHIELD THERAPEUTICS PLC ORD GBP0.015 and suggest that you do with its stocks.
STX stock is 7.69% volatile and has beta coefficient of 0.16. Track SHIELD THERAPEUTICS PLC ORD GBP0.015 stock price on the chart and check out the list of the most volatile stocks — is SHIELD THERAPEUTICS PLC ORD GBP0.015 there?
Today SHIELD THERAPEUTICS PLC ORD GBP0.015 has the market capitalization of 28.13 M, it has increased by 33.20% over the last week.
Yes, you can track SHIELD THERAPEUTICS PLC ORD GBP0.015 financials in yearly and quarterly reports right on TradingView.
SHIELD THERAPEUTICS PLC ORD GBP0.015 is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
STX net income for the last half-year is −12.24 M GBP, while the previous report showed −16.51 M GBP of net income which accounts for 25.88% change. Track more SHIELD THERAPEUTICS PLC ORD GBP0.015 financial stats to get the full picture.
No, STX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 73.00 employees. See our rating of the largest employees — is SHIELD THERAPEUTICS PLC ORD GBP0.015 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHIELD THERAPEUTICS PLC ORD GBP0.015 EBITDA is −26.13 M GBP, and current EBITDA margin is −264.98%. See more stats in SHIELD THERAPEUTICS PLC ORD GBP0.015 financial statements.
Like other stocks, STX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHIELD THERAPEUTICS PLC ORD GBP0.015 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHIELD THERAPEUTICS PLC ORD GBP0.015 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHIELD THERAPEUTICS PLC ORD GBP0.015 stock shows the sell signal. See more of SHIELD THERAPEUTICS PLC ORD GBP0.015 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.